PAQ Therapeutics
PrivateLast Round
Series B
Extension
Jan 22, 2026
Total Funding Raised
$153M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
PAQ Therapeutics is a biotechnology company developing best- and first-in-class KRAS degraders for lethal cancers lacking effective treatment options.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
PAQ Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
PAQ Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Jan 22, 2026 | ||||
| Series B | May 7, 2025 | ||||
| Series A | Jul 15, 2021 | ||||
| Seed | Nov 8, 2020 | ||||
| Seed | Jun 1, 2020 |
PAQ Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Matrix | Seed, Series A |
| BioTrack Capital | Series B Extension, Series B |
| Nest Bio Ventures | Seed, Series A |
| MSA Capital | Series A |
| Bayland Capital | Series B Extension |
| MPC | Seed, Series A |
| Huagai Capital | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors grew 398% MoM, from 386 to 1.9K.
- Jan 22, 2026
$38M round with participation from Merck and J&J.
PAQ Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about PAQ Therapeutics's valuation, stock price, and market status.